Mazor Robotics (NSDQ:MZOR) said today that it won CE Mark approval in the European Union for its Mazor X robot-assisted surgery platform, setting the stage for strategic backer Medtronic (NYSE:MDT) to put the device on the European market.
“Receipt of the CE Mark is an important step in our plan to expand the patient, surgeon and hospital benefits of the Mazor X surgical assurance platform to the European market,” CEO Ori Hadomi said in prepared remarks. “Our commercial partner for the Mazor X, Medtronic, will be responsible for marketing and selling the system in Europe and we look forward to working with them to ensure a successful launch.”
Get the full story at our sister site, The Robot Report.
The post Mazor Robotics wins CE Mark for Mazor X surgery platform appeared first on MassDevice.
from MassDevice http://ift.tt/2xvYlKP
Cap comentari:
Publica un comentari a l'entrada